The global Clinical Trials Matching Software Market was valued at USD 187.14 million in 2024, expected to reach USD 501.86 million by 2032, with a CAGR of 13.14%. The U.S. segment is projected to hit USD 199.51 million by 2032, driven by advanced healthcare-IT infrastructure and rising clinical trial volume.

Demand for high-precision patient matching is growing due to complex trials, tighter eligibility criteria, and pressure to accelerate enrollment. Leading platforms integrate EHRs, offer real-time eligibility screening, and enhance patient outreach. Personalized matching and cloud-enabled tools are key as the industry shifts towards decentralized trials.

North America dominated the market in 2024, with Asia Pacific expected to witness the fastest growth at a projected CAGR of 13.94% from 2025 to 2032. Recent developments include AI-driven patient matching enhancements and expanded patient engagement tools.

Exclusive sections of the report cover Software Adoption & AI Integration Metrics, Patient Enrollment & Demographic Insights, Interoperability & Platform Integration Index, Sponsor & Site Utilization Benchmarks, Cost Efficiency & ROI Analytics, and Technological Competitiveness Landscape. Get free sample report and customization options. SNS Insider offers detailed analysis of the Clinical Trials Matching Software Market. With a focus on providing accurate market data and consumer insights, the leading market research agency aims to empower clients to make informed decisions in a rapidly changing environment. Access the complete report for in-depth information and analysis. Contact [email protected] for customization requests.

Read more at GlobeNewswire: Clinical Trials Matching Software Market Size to Reach USD